Global Prostate Cancer Diagnostics Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
According to APO Research, The global Prostate Cancer Diagnostics market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Prostate Cancer Diagnostics include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics.
The Prostate Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Cancer Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prostate Cancer Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Cancer Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Prostate Cancer Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
According to APO Research, The global Prostate Cancer Diagnostics market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Prostate Cancer Diagnostics include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics.
The Prostate Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- OPKO
- Genomic Health
- Abbott
- Beckman Coulter
- Siemens Healthcare
- bioMeriux
- Roche
- MDx Health
- DiaSorin
- Myriad Genetics
- Ambry Genetics
- Tumor Biomarker Tests
- Imaging
- Biopsy
- Other
- Age Below 55
- Age 55-75
- Age Above 75
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Cancer Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prostate Cancer Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Cancer Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Prostate Cancer Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Prostate Cancer Diagnostics Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Prostate Cancer Diagnostics Market Size by Region (2019-2030)
1.4.1 Global Prostate Cancer Diagnostics Market Size by Region (2019-2024)
1.4.2 Global Prostate Cancer Diagnostics Market Size by Region (2025-2030)
1.5 Key Regions Prostate Cancer Diagnostics Market Size (2019-2030)
1.5.1 North America Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030)
1.5.2 Europe Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030)
1.5.4 Latin America Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030)
2 PROSTATE CANCER DIAGNOSTICS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Tumor Biomarker Tests
2.1.2 Imaging
2.1.3 Biopsy
2.1.4 Other
2.2 Global Prostate Cancer Diagnostics Market Size by Type
2.2.1 Global Prostate Cancer Diagnostics Market Size Overview by Type (2019-2030)
2.2.2 Global Prostate Cancer Diagnostics Historic Market Size Review by Type (2019-2024)
2.2.3 Global Prostate Cancer Diagnostics Market Size Forecasted by Type (2025-2030)
2.3 Global Prostate Cancer Diagnostics Market Size by Regions
2.3.1 North America Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024)
3 PROSTATE CANCER DIAGNOSTICS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Age Below
3.1.2 Age 55-75
3.1.3 Age Above
3.2 Global Prostate Cancer Diagnostics Market Size by Application
3.2.1 Global Prostate Cancer Diagnostics Market Size Overview by Application (2019-2030)
3.2.2 Global Prostate Cancer Diagnostics Historic Market Size Review by Application (2019-2024)
3.2.3 Global Prostate Cancer Diagnostics Market Size Forecasted by Application (2025-2030)
3.3 Global Prostate Cancer Diagnostics Market Size by Regions
3.3.1 North America Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Prostate Cancer Diagnostics Industry Trends
4.2 Prostate Cancer Diagnostics Industry Drivers
4.3 Prostate Cancer Diagnostics Industry Opportunities and Challenges
4.4 Prostate Cancer Diagnostics Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Prostate Cancer Diagnostics Revenue (2019-2024)
5.2 Global Prostate Cancer Diagnostics Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Prostate Cancer Diagnostics Key Company Headquarters & Area Served
5.4 Global Prostate Cancer Diagnostics Company, Product Type & Application
5.5 Global Prostate Cancer Diagnostics Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Prostate Cancer Diagnostics Market CR5 and HHI
5.6.2 Global Top 5 and 10 Prostate Cancer Diagnostics Players Market Share by Revenue in 2023
5.6.3 2023 Prostate Cancer Diagnostics Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 OPKO
6.1.1 OPKO Comapny Information
6.1.2 OPKO Business Overview
6.1.3 OPKO Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 OPKO Prostate Cancer Diagnostics Product Portfolio
6.1.5 OPKO Recent Developments
6.2 Genomic Health
6.2.1 Genomic Health Comapny Information
6.2.2 Genomic Health Business Overview
6.2.3 Genomic Health Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Genomic Health Prostate Cancer Diagnostics Product Portfolio
6.2.5 Genomic Health Recent Developments
6.3 Abbott
6.3.1 Abbott Comapny Information
6.3.2 Abbott Business Overview
6.3.3 Abbott Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Abbott Prostate Cancer Diagnostics Product Portfolio
6.3.5 Abbott Recent Developments
6.4 Beckman Coulter
6.4.1 Beckman Coulter Comapny Information
6.4.2 Beckman Coulter Business Overview
6.4.3 Beckman Coulter Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
6.4.5 Beckman Coulter Recent Developments
6.5 Siemens Healthcare
6.5.1 Siemens Healthcare Comapny Information
6.5.2 Siemens Healthcare Business Overview
6.5.3 Siemens Healthcare Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
6.5.5 Siemens Healthcare Recent Developments
6.6 bioMeriux
6.6.1 bioMeriux Comapny Information
6.6.2 bioMeriux Business Overview
6.6.3 bioMeriux Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 bioMeriux Prostate Cancer Diagnostics Product Portfolio
6.6.5 bioMeriux Recent Developments
6.7 Roche
6.7.1 Roche Comapny Information
6.7.2 Roche Business Overview
6.7.3 Roche Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Roche Prostate Cancer Diagnostics Product Portfolio
6.7.5 Roche Recent Developments
6.8 MDx Health
6.8.1 MDx Health Comapny Information
6.8.2 MDx Health Business Overview
6.8.3 MDx Health Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 MDx Health Prostate Cancer Diagnostics Product Portfolio
6.8.5 MDx Health Recent Developments
6.9 DiaSorin
6.9.1 DiaSorin Comapny Information
6.9.2 DiaSorin Business Overview
6.9.3 DiaSorin Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 DiaSorin Prostate Cancer Diagnostics Product Portfolio
6.9.5 DiaSorin Recent Developments
6.10 Myriad Genetics
6.10.1 Myriad Genetics Comapny Information
6.10.2 Myriad Genetics Business Overview
6.10.3 Myriad Genetics Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
6.10.5 Myriad Genetics Recent Developments
6.11 Ambry Genetics
6.11.1 Ambry Genetics Comapny Information
6.11.2 Ambry Genetics Business Overview
6.11.3 Ambry Genetics Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
6.11.5 Ambry Genetics Recent Developments
7 NORTH AMERICA
7.1 North America Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Prostate Cancer Diagnostics Market Size by Country (2019-2024)
7.3 North America Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Prostate Cancer Diagnostics Market Size by Country (2019-2024)
8.3 Europe Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Prostate Cancer Diagnostics Market Size by Country (2019-2024)
9.3 Asia-Pacific Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Prostate Cancer Diagnostics Market Size by Country (2019-2024)
10.3 Latin America Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2019-2024)
11.3 Middle East & Africa Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Prostate Cancer Diagnostics Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Prostate Cancer Diagnostics Market Size by Region (2019-2030)
1.4.1 Global Prostate Cancer Diagnostics Market Size by Region (2019-2024)
1.4.2 Global Prostate Cancer Diagnostics Market Size by Region (2025-2030)
1.5 Key Regions Prostate Cancer Diagnostics Market Size (2019-2030)
1.5.1 North America Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030)
1.5.2 Europe Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030)
1.5.4 Latin America Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030)
2 PROSTATE CANCER DIAGNOSTICS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Tumor Biomarker Tests
2.1.2 Imaging
2.1.3 Biopsy
2.1.4 Other
2.2 Global Prostate Cancer Diagnostics Market Size by Type
2.2.1 Global Prostate Cancer Diagnostics Market Size Overview by Type (2019-2030)
2.2.2 Global Prostate Cancer Diagnostics Historic Market Size Review by Type (2019-2024)
2.2.3 Global Prostate Cancer Diagnostics Market Size Forecasted by Type (2025-2030)
2.3 Global Prostate Cancer Diagnostics Market Size by Regions
2.3.1 North America Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024)
3 PROSTATE CANCER DIAGNOSTICS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Age Below
3.1.2 Age 55-75
3.1.3 Age Above
3.2 Global Prostate Cancer Diagnostics Market Size by Application
3.2.1 Global Prostate Cancer Diagnostics Market Size Overview by Application (2019-2030)
3.2.2 Global Prostate Cancer Diagnostics Historic Market Size Review by Application (2019-2024)
3.2.3 Global Prostate Cancer Diagnostics Market Size Forecasted by Application (2025-2030)
3.3 Global Prostate Cancer Diagnostics Market Size by Regions
3.3.1 North America Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Prostate Cancer Diagnostics Industry Trends
4.2 Prostate Cancer Diagnostics Industry Drivers
4.3 Prostate Cancer Diagnostics Industry Opportunities and Challenges
4.4 Prostate Cancer Diagnostics Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Prostate Cancer Diagnostics Revenue (2019-2024)
5.2 Global Prostate Cancer Diagnostics Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Prostate Cancer Diagnostics Key Company Headquarters & Area Served
5.4 Global Prostate Cancer Diagnostics Company, Product Type & Application
5.5 Global Prostate Cancer Diagnostics Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Prostate Cancer Diagnostics Market CR5 and HHI
5.6.2 Global Top 5 and 10 Prostate Cancer Diagnostics Players Market Share by Revenue in 2023
5.6.3 2023 Prostate Cancer Diagnostics Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 OPKO
6.1.1 OPKO Comapny Information
6.1.2 OPKO Business Overview
6.1.3 OPKO Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 OPKO Prostate Cancer Diagnostics Product Portfolio
6.1.5 OPKO Recent Developments
6.2 Genomic Health
6.2.1 Genomic Health Comapny Information
6.2.2 Genomic Health Business Overview
6.2.3 Genomic Health Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Genomic Health Prostate Cancer Diagnostics Product Portfolio
6.2.5 Genomic Health Recent Developments
6.3 Abbott
6.3.1 Abbott Comapny Information
6.3.2 Abbott Business Overview
6.3.3 Abbott Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Abbott Prostate Cancer Diagnostics Product Portfolio
6.3.5 Abbott Recent Developments
6.4 Beckman Coulter
6.4.1 Beckman Coulter Comapny Information
6.4.2 Beckman Coulter Business Overview
6.4.3 Beckman Coulter Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
6.4.5 Beckman Coulter Recent Developments
6.5 Siemens Healthcare
6.5.1 Siemens Healthcare Comapny Information
6.5.2 Siemens Healthcare Business Overview
6.5.3 Siemens Healthcare Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
6.5.5 Siemens Healthcare Recent Developments
6.6 bioMeriux
6.6.1 bioMeriux Comapny Information
6.6.2 bioMeriux Business Overview
6.6.3 bioMeriux Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 bioMeriux Prostate Cancer Diagnostics Product Portfolio
6.6.5 bioMeriux Recent Developments
6.7 Roche
6.7.1 Roche Comapny Information
6.7.2 Roche Business Overview
6.7.3 Roche Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Roche Prostate Cancer Diagnostics Product Portfolio
6.7.5 Roche Recent Developments
6.8 MDx Health
6.8.1 MDx Health Comapny Information
6.8.2 MDx Health Business Overview
6.8.3 MDx Health Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 MDx Health Prostate Cancer Diagnostics Product Portfolio
6.8.5 MDx Health Recent Developments
6.9 DiaSorin
6.9.1 DiaSorin Comapny Information
6.9.2 DiaSorin Business Overview
6.9.3 DiaSorin Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 DiaSorin Prostate Cancer Diagnostics Product Portfolio
6.9.5 DiaSorin Recent Developments
6.10 Myriad Genetics
6.10.1 Myriad Genetics Comapny Information
6.10.2 Myriad Genetics Business Overview
6.10.3 Myriad Genetics Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
6.10.5 Myriad Genetics Recent Developments
6.11 Ambry Genetics
6.11.1 Ambry Genetics Comapny Information
6.11.2 Ambry Genetics Business Overview
6.11.3 Ambry Genetics Prostate Cancer Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
6.11.5 Ambry Genetics Recent Developments
7 NORTH AMERICA
7.1 North America Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Prostate Cancer Diagnostics Market Size by Country (2019-2024)
7.3 North America Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Prostate Cancer Diagnostics Market Size by Country (2019-2024)
8.3 Europe Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Prostate Cancer Diagnostics Market Size by Country (2019-2024)
9.3 Asia-Pacific Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Prostate Cancer Diagnostics Market Size by Country (2019-2024)
10.3 Latin America Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2019-2024)
11.3 Middle East & Africa Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
LIST OF TABLES
Table 1. Global Prostate Cancer Diagnostics Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Prostate Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Prostate Cancer Diagnostics Market Share by Region (2019-2024)
Table 4. Global Prostate Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Prostate Cancer Diagnostics Market Share by Region (2025-2030)
Table 6. Global Prostate Cancer Diagnostics Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Prostate Cancer Diagnostics Market Size Share by Type (2019-2024)
Table 9. Global Prostate Cancer Diagnostics Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Prostate Cancer Diagnostics Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Prostate Cancer Diagnostics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Prostate Cancer Diagnostics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Prostate Cancer Diagnostics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Prostate Cancer Diagnostics Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Prostate Cancer Diagnostics Market Size Share by Application (2019-2024)
Table 24. Global Prostate Cancer Diagnostics Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Prostate Cancer Diagnostics Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Prostate Cancer Diagnostics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Prostate Cancer Diagnostics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Prostate Cancer Diagnostics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Prostate Cancer Diagnostics Industry Trends
Table 37. Prostate Cancer Diagnostics Industry Drivers
Table 38. Prostate Cancer Diagnostics Industry Opportunities and Challenges
Table 39. Prostate Cancer Diagnostics Industry Restraints
Table 40. Global Prostate Cancer Diagnostics Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Prostate Cancer Diagnostics Revenue Market Share by Company (2019-2024)
Table 42. Global Prostate Cancer Diagnostics Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Prostate Cancer Diagnostics Key Company Headquarters & Area Served
Table 44. Global Prostate Cancer Diagnostics Company, Product Type & Application
Table 45. Global Prostate Cancer Diagnostics Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. OPKO Business Overview
Table 49. OPKO Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. OPKO Prostate Cancer Diagnostics Product Portfolio
Table 51. OPKO Recent Development
Table 52. Genomic Health Company Information
Table 53. Genomic Health Business Overview
Table 54. Genomic Health Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Genomic Health Prostate Cancer Diagnostics Product Portfolio
Table 56. Genomic Health Recent Development
Table 57. Abbott Company Information
Table 58. Abbott Business Overview
Table 59. Abbott Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Abbott Prostate Cancer Diagnostics Product Portfolio
Table 61. Abbott Recent Development
Table 62. Beckman Coulter Company Information
Table 63. Beckman Coulter Business Overview
Table 64. Beckman Coulter Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
Table 66. Beckman Coulter Recent Development
Table 67. Siemens Healthcare Company Information
Table 68. Siemens Healthcare Business Overview
Table 69. Siemens Healthcare Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
Table 71. Siemens Healthcare Recent Development
Table 72. bioMeriux Company Information
Table 73. bioMeriux Business Overview
Table 74. bioMeriux Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. bioMeriux Prostate Cancer Diagnostics Product Portfolio
Table 76. bioMeriux Recent Development
Table 77. Roche Company Information
Table 78. Roche Business Overview
Table 79. Roche Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Roche Prostate Cancer Diagnostics Product Portfolio
Table 81. Roche Recent Development
Table 82. MDx Health Company Information
Table 83. MDx Health Business Overview
Table 84. MDx Health Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. MDx Health Prostate Cancer Diagnostics Product Portfolio
Table 86. MDx Health Recent Development
Table 87. DiaSorin Company Information
Table 88. DiaSorin Business Overview
Table 89. DiaSorin Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. DiaSorin Prostate Cancer Diagnostics Product Portfolio
Table 91. DiaSorin Recent Development
Table 92. Myriad Genetics Company Information
Table 93. Myriad Genetics Business Overview
Table 94. Myriad Genetics Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
Table 96. Myriad Genetics Recent Development
Table 97. Ambry Genetics Company Information
Table 98. Ambry Genetics Business Overview
Table 99. Ambry Genetics Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
Table 101. Ambry Genetics Recent Development
Table 102. North America Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 103. North America Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 104. North America Prostate Cancer Diagnostics Market Share by Country (2019-2024)
Table 105. North America Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 106. North America Prostate Cancer Diagnostics Market Share Forecast by Country (2025-2030)
Table 107. Europe Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 108. Europe Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 109. Europe Prostate Cancer Diagnostics Market Share by Country (2019-2024)
Table 110. Europe Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 111. Europe Prostate Cancer Diagnostics Market Share Forecast by Country (2025-2030)
Table 112. Asia-Pacific Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. Asia-Pacific Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 114. Asia-Pacific Prostate Cancer Diagnostics Market Share by Country (2019-2024)
Table 115. Asia-Pacific Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. Asia-Pacific Prostate Cancer Diagnostics Market Share Forecast by Country (2025-2030)
Table 117. Latin America Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 118. Latin America Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 119. Latin America Prostate Cancer Diagnostics Market Share by Country (2019-2024)
Table 120. Latin America Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 121. Latin America Prostate Cancer Diagnostics Market Share Forecast by Country (2025-2030)
Table 122. Middle East & Africa Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 124. Middle East & Africa Prostate Cancer Diagnostics Market Share by Country (2019-2024)
Table 125. Middle East & Africa Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. Middle East & Africa Prostate Cancer Diagnostics Market Share Forecast by Country (2025-2030)
Table 127. Research Programs/Design for This Report
Table 128. Authors List of This Report
Table 129. Secondary Sources
Table 130. Primary Sources
Table 1. Global Prostate Cancer Diagnostics Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Prostate Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Prostate Cancer Diagnostics Market Share by Region (2019-2024)
Table 4. Global Prostate Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Prostate Cancer Diagnostics Market Share by Region (2025-2030)
Table 6. Global Prostate Cancer Diagnostics Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Prostate Cancer Diagnostics Market Size Share by Type (2019-2024)
Table 9. Global Prostate Cancer Diagnostics Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Prostate Cancer Diagnostics Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Prostate Cancer Diagnostics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Prostate Cancer Diagnostics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Prostate Cancer Diagnostics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Prostate Cancer Diagnostics Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Prostate Cancer Diagnostics Market Size Share by Application (2019-2024)
Table 24. Global Prostate Cancer Diagnostics Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Prostate Cancer Diagnostics Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Prostate Cancer Diagnostics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Prostate Cancer Diagnostics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Prostate Cancer Diagnostics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Prostate Cancer Diagnostics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Prostate Cancer Diagnostics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Prostate Cancer Diagnostics Industry Trends
Table 37. Prostate Cancer Diagnostics Industry Drivers
Table 38. Prostate Cancer Diagnostics Industry Opportunities and Challenges
Table 39. Prostate Cancer Diagnostics Industry Restraints
Table 40. Global Prostate Cancer Diagnostics Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Prostate Cancer Diagnostics Revenue Market Share by Company (2019-2024)
Table 42. Global Prostate Cancer Diagnostics Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Prostate Cancer Diagnostics Key Company Headquarters & Area Served
Table 44. Global Prostate Cancer Diagnostics Company, Product Type & Application
Table 45. Global Prostate Cancer Diagnostics Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. OPKO Business Overview
Table 49. OPKO Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. OPKO Prostate Cancer Diagnostics Product Portfolio
Table 51. OPKO Recent Development
Table 52. Genomic Health Company Information
Table 53. Genomic Health Business Overview
Table 54. Genomic Health Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Genomic Health Prostate Cancer Diagnostics Product Portfolio
Table 56. Genomic Health Recent Development
Table 57. Abbott Company Information
Table 58. Abbott Business Overview
Table 59. Abbott Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Abbott Prostate Cancer Diagnostics Product Portfolio
Table 61. Abbott Recent Development
Table 62. Beckman Coulter Company Information
Table 63. Beckman Coulter Business Overview
Table 64. Beckman Coulter Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
Table 66. Beckman Coulter Recent Development
Table 67. Siemens Healthcare Company Information
Table 68. Siemens Healthcare Business Overview
Table 69. Siemens Healthcare Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
Table 71. Siemens Healthcare Recent Development
Table 72. bioMeriux Company Information
Table 73. bioMeriux Business Overview
Table 74. bioMeriux Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. bioMeriux Prostate Cancer Diagnostics Product Portfolio
Table 76. bioMeriux Recent Development
Table 77. Roche Company Information
Table 78. Roche Business Overview
Table 79. Roche Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Roche Prostate Cancer Diagnostics Product Portfolio
Table 81. Roche Recent Development
Table 82. MDx Health Company Information
Table 83. MDx Health Business Overview
Table 84. MDx Health Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. MDx Health Prostate Cancer Diagnostics Product Portfolio
Table 86. MDx Health Recent Development
Table 87. DiaSorin Company Information
Table 88. DiaSorin Business Overview
Table 89. DiaSorin Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. DiaSorin Prostate Cancer Diagnostics Product Portfolio
Table 91. DiaSorin Recent Development
Table 92. Myriad Genetics Company Information
Table 93. Myriad Genetics Business Overview
Table 94. Myriad Genetics Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
Table 96. Myriad Genetics Recent Development
Table 97. Ambry Genetics Company Information
Table 98. Ambry Genetics Business Overview
Table 99. Ambry Genetics Prostate Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
Table 101. Ambry Genetics Recent Development
Table 102. North America Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 103. North America Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 104. North America Prostate Cancer Diagnostics Market Share by Country (2019-2024)
Table 105. North America Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 106. North America Prostate Cancer Diagnostics Market Share Forecast by Country (2025-2030)
Table 107. Europe Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 108. Europe Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 109. Europe Prostate Cancer Diagnostics Market Share by Country (2019-2024)
Table 110. Europe Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 111. Europe Prostate Cancer Diagnostics Market Share Forecast by Country (2025-2030)
Table 112. Asia-Pacific Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. Asia-Pacific Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 114. Asia-Pacific Prostate Cancer Diagnostics Market Share by Country (2019-2024)
Table 115. Asia-Pacific Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. Asia-Pacific Prostate Cancer Diagnostics Market Share Forecast by Country (2025-2030)
Table 117. Latin America Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 118. Latin America Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 119. Latin America Prostate Cancer Diagnostics Market Share by Country (2019-2024)
Table 120. Latin America Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 121. Latin America Prostate Cancer Diagnostics Market Share Forecast by Country (2025-2030)
Table 122. Middle East & Africa Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 124. Middle East & Africa Prostate Cancer Diagnostics Market Share by Country (2019-2024)
Table 125. Middle East & Africa Prostate Cancer Diagnostics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. Middle East & Africa Prostate Cancer Diagnostics Market Share Forecast by Country (2025-2030)
Table 127. Research Programs/Design for This Report
Table 128. Authors List of This Report
Table 129. Secondary Sources
Table 130. Primary Sources
LIST OF FIGURES
Figure 1. Prostate Cancer Diagnostics Product Picture
Figure 2. Global Prostate Cancer Diagnostics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 4. Global Prostate Cancer Diagnostics Market Share by Region: 2023 VS 2030
Figure 5. Global Prostate Cancer Diagnostics Market Share by Region (2019-2030)
Figure 6. North America Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Tumor Biomarker Tests
Figure 12. Global Tumor Biomarker Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Imaging
Figure 14. Global Imaging Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of Biopsy
Figure 16. Global Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of Other
Figure 18. Global Other Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Global Prostate Cancer Diagnostics Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 20. Global Prostate Cancer Diagnostics Market Share by Type 2023 VS 2030
Figure 21. North America Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
Figure 22. Europe Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
Figure 23. Asia-Pacific Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
Figure 24. Latin America Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
Figure 25. Middle East and Africa Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
Figure 26. Product Picture of Age Below 55
Figure 27. Global Age Below 55 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Product Picture of Age 55-75
Figure 29. Global Age 55-75 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Product Picture of Age Above 75
Figure 31. Global Age Above 75 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Global Prostate Cancer Diagnostics Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 33. Global Prostate Cancer Diagnostics Market Share by Application 2023 VS 2030
Figure 34. North America Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
Figure 35. Europe Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
Figure 36. Asia-Pacific Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
Figure 37. Latin America Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
Figure 38. Middle East and Africa Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
Figure 39. Global Top 5 and 10 Prostate Cancer Diagnostics Players Market Share by Revenue in 2023
Figure 40. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 41. North America Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Prostate Cancer Diagnostics Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 44. Europe Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 45. Europe Prostate Cancer Diagnostics Market Share by Country: 2019 VS 2023 VS 2030
Figure 46. Europe Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 47. Asia-Pacific Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Asia-Pacific Prostate Cancer Diagnostics Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 50. Latin America Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Latin America Prostate Cancer Diagnostics Market Share by Country: 2019 VS 2023 VS 2030
Figure 52. Latin America Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Middle East & Africa Prostate Cancer Diagnostics Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East & Africa Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 56. Years Considered
Figure 57. Research Process
Figure 58. Key Executives Interviewed
Figure 1. Prostate Cancer Diagnostics Product Picture
Figure 2. Global Prostate Cancer Diagnostics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 4. Global Prostate Cancer Diagnostics Market Share by Region: 2023 VS 2030
Figure 5. Global Prostate Cancer Diagnostics Market Share by Region (2019-2030)
Figure 6. North America Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Prostate Cancer Diagnostics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Tumor Biomarker Tests
Figure 12. Global Tumor Biomarker Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Imaging
Figure 14. Global Imaging Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of Biopsy
Figure 16. Global Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of Other
Figure 18. Global Other Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Global Prostate Cancer Diagnostics Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 20. Global Prostate Cancer Diagnostics Market Share by Type 2023 VS 2030
Figure 21. North America Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
Figure 22. Europe Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
Figure 23. Asia-Pacific Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
Figure 24. Latin America Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
Figure 25. Middle East and Africa Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
Figure 26. Product Picture of Age Below 55
Figure 27. Global Age Below 55 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Product Picture of Age 55-75
Figure 29. Global Age 55-75 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Product Picture of Age Above 75
Figure 31. Global Age Above 75 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Global Prostate Cancer Diagnostics Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 33. Global Prostate Cancer Diagnostics Market Share by Application 2023 VS 2030
Figure 34. North America Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
Figure 35. Europe Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
Figure 36. Asia-Pacific Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
Figure 37. Latin America Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
Figure 38. Middle East and Africa Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
Figure 39. Global Top 5 and 10 Prostate Cancer Diagnostics Players Market Share by Revenue in 2023
Figure 40. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 41. North America Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Prostate Cancer Diagnostics Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 44. Europe Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 45. Europe Prostate Cancer Diagnostics Market Share by Country: 2019 VS 2023 VS 2030
Figure 46. Europe Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 47. Asia-Pacific Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Asia-Pacific Prostate Cancer Diagnostics Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 50. Latin America Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Latin America Prostate Cancer Diagnostics Market Share by Country: 2019 VS 2023 VS 2030
Figure 52. Latin America Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Middle East & Africa Prostate Cancer Diagnostics Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East & Africa Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 56. Years Considered
Figure 57. Research Process
Figure 58. Key Executives Interviewed
